Wiley Bros. Aintree Capital, LLC Illumina, Inc. Transaction History
Wiley Bros. Aintree Capital, LLC
- $14.9 Billion
- Q3 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Illumina, Inc. stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 2,235 shares of ILMN stock, worth $269,697. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,235Holding current value
$269,697% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ILMN
# of Institutions
909Shares Held
157MCall Options Held
4.75MPut Options Held
903K-
Capital World Investors Los Angeles, CA20MShares$2.41 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY18.1MShares$2.18 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$1.77 Billion0.02% of portfolio
-
State Street Corp Boston, MA6MShares$724 Million0.02% of portfolio
-
Sessa Capital Im, L.P. New York, NY4.69MShares$566 Million10.94% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $19B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....